Literature DB >> 20960455

Factors effecting the morphology of Eudragit S-100 based microsponges bearing dicyclomine for colonic delivery.

Vikas Jain1, Deepika Jain, Ranjit Singh.   

Abstract

The purpose of this study was to design microsponge-based novel colon-specific drug delivery system bearing dicyclomine. Eudragit S-100-based microsponges containing the drug in varying amount were prepared using quasi-emulsion solvent diffusion method. The microsponges were prepared by optimizing various process parameters. Differential scanning calorimetry and Fourier transform infrared studies indicated compatibility and stability of the drug in various formulations. Shape and surface morphology of the microsponges were examined using scanning electron microscopy. The formulations were subjected to in vitro release studies, and the results were evaluated kinetically and statistically. In vitro release data showed a biphasic pattern with an initial burst effect. In the first hour, drug release from microsponges was found to be between 17% and 31%. The cumulative percent release at the end of eighth hour was noted to be between 53% and 83%. The release kinetics showed that the data followed Higuchi model and the main mechanism of drug release was diffusion. The colon-specific tablets were prepared by compressing the microsponges followed by coating with pectin:hydroxypropylmethylcellulose mixture. In vitro release studies exhibited that compression-coated colon-specific formulations started releasing the drug at the sixth hour corresponding to the arrival time at colon. The study presents a new approach for colon-specific drug delivery.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Keywords:  FTIR; calorimetry (DSC); colonic drug delivery; diffusion; gastrointestinal transit

Mesh:

Substances:

Year:  2010        PMID: 20960455     DOI: 10.1002/jps.22360

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Development and in vitro-in vivo evaluation of fenretinide-loaded oral mucoadhesive patches for site-specific chemoprevention of oral cancer.

Authors:  Kashappa-Goud H Desai; Susan R Mallery; Andrew S Holpuch; Steven P Schwendeman
Journal:  Pharm Res       Date:  2011-06-15       Impact factor: 4.200

2.  Development of sustained-release microspheres for the delivery of SAR 1118, an LFA-1 antagonist intended for the treatment of vascular complications of the eye.

Authors:  Sarath Yandrapu; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-20       Impact factor: 2.671

3.  Evaluation of paeonol skin-target delivery from its microsponge formulation: in vitro skin permeation and in vivo microdialysis.

Authors:  Sha-Sha Li; Guo-Feng Li; Li Liu; Xiao Jiang; Bin Zhang; Zhi-Gang Liu; Xue-Ling Li; Li-Dong Weng; Ting Zuo; Qiang Liu
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

4.  Formulation and evaluation of curcumin microsponges for oral and topical drug delivery.

Authors:  Meenakshi Bhatia; Megha Saini
Journal:  Prog Biomater       Date:  2018-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.